D.E. Shaw & Co
ACHV icon

D.E. Shaw & Co’s Achieve Life Sciences ACHV Stock Holding History

D.E. Shaw & Co’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6
Closed -$9K – 3319
2016
Q1 		$9K Hold
6
– – ﹤0.01% 3360
2015
Q4 		$16K Buy
+6
New +$25.4K ﹤0.01% 3747
2015
Q3 		– Sell
-17
Closed -$85K – 3696
2015
Q2 		$85K Sell
17
-5
-23% -$24.8K ﹤0.01% 3662
2015
Q1 		$103K Sell
22
-43
-66% -$211K ﹤0.01% 3524
2014
Q4 		$325K Buy
65
+33
+103% +$161K ﹤0.01% 3610
2014
Q3 		$188K Buy
32
+10
+45% +$69.5K ﹤0.01% 3910
2014
Q2 		$180K Buy
+22
New +$270K ﹤0.01% 4012
2013
Q3 		– Sell
-5
Closed -$98K – 4254
2013
Q2 		$98K Buy
+5
New +$112K ﹤0.01% 3879

Other funds holding ACHV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co's ACHV Position: Q2 2016 in Review

D.E. Shaw & Co sold out of Achieve Life Sciences (ACHV) in Q2 2016, closing a stake of 6 shares — an estimated $9K sold.

D.E. Shaw & Co first reported a position in ACHV in Q2 2013 and held it in 8 quarters. The position peaked at $325K in Q4 2014. 34 funds tracked by Wall St. Rank hold ACHV as of Q2 2016.

  • D.E. Shaw & Co reported no remaining Achieve Life Sciences position as of Q2 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 6 Achieve Life Sciences shares in Q2 2016, an estimated $9K.
  • D.E. Shaw & Co first reported a position in Achieve Life Sciences in Q2 2013 and held it in 8 quarters.
  • D.E. Shaw & Co's Achieve Life Sciences position peaked at $325K in Q4 2014.
  • 34 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2016.

Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.